OHDSI Home | Forums | Wiki | Github

Weekly OHDSI Digest-14Feb2022

WEEKLY COMMUNITY CALL MEETINGS

Please join us Tuesday, Feb. 15 (11 am ET) for our next OHDSI community call, which will include a trio of presentations:

Clair Blacketer will share the 2022 OKRs, which include a series of CDM workshops, during the Common Data Model Workgroup presentation

Clair Blacketer will also present the annual update and 2022 OKRs for the Data Quality Dashboard Development Workgroup

Patrick Ryan will provide the second update on Phenotype Phebruary, which you can join in the daily conversations at the OHDSI forums or at the event homepage

Everybody is invited. Calendar invites for our 2022 community calls went out two weeks ago. If you did not receive one, please use this link to join the meeting. All recordings from these weekly meetings will be posted on both our main OHDSI Teams tenant and on our OHDSI.org Community Calls page.

WEEKLY WORKING GROUP CALL MEETINGS

Common Data Model WG: Tuesday, Feb 15 at 1 pm ET (Meeting Link)
Meetings are traditionally scheduled for the first and third Tuesdays of each month at 10am and 1 pm ET, respectively.

FHIR and OMOP WG – Data Model Harmonization Subgroup Meeting: Wednesday, Feb. 16 at 9 am ET (Eastern Hemisphere) (Meeting Link) Meetings are traditionally scheduled for the 3rd Wednesday of each month at 9am ET. NOTE: This meeting takes place on Zoom but please check the Teams Work Group for information & updates (Meeting ID: 971 1680 7510 Passcode: 143545)

Africa Chapter Meeting: Wednesday, Feb 16 at 9 am ET (Meeting Link)
Meetings are traditionally scheduled for the third Wednesday of each month at 9 am ET

FHIR and OMOP WG- Digital Quality Measurements Subgroup: Wed. Feb. 16 at 10am ET (Meeting Link)
Meetings are traditionally scheduled for every other Wednesday at 10 am ET. NOTE: This meeting takes place on Zoom but please check the Teams Work Group for information and updates Zoom Details: Meeting ID: 836 4585 6405 Passcode: 552204

Health Equity Journal Club: Wednesday, Feb. 16 at 12pm ET (Meeting Link)
Meetings are traditionally scheduled for the third Wednesday of each month at 12 pm ET.

Psychiatry WG: Thursday, Feb. 17 at 8 am ET (Meeting Link)
Meetings are traditionally scheduled for every other Thursday at 8 am ET.

HADES WG: Thursday, Feb. 17 at 12 pm ET (Meeting Link)
Meetings are traditionally scheduled for the third Thursday of each month at 12 pm ET.

FHIR and OMOP WG-Oncology Subgroup: Thursday, Feb. 17 at 12 pm ET (Meeting Link)
Meetings are traditionally scheduled for every other Thursday at 12pm ET

FHIR and OMOP WG-Terminologies Subgroup: Meeting: Thursday, Feb. 17 at 6pm ET (Pacific & Western Time zone participants) : (Meeting Link)
Meetings are traditionally scheduled for every other Thursday at 6pm ET. NOTE: This meeting takes place on Zoom but please check the Teams Work Group for information and updates (Meeting ID: 685 509 3136 Passcode: 710256)

Vaccine Vocabulary WG: Friday, Feb 18 at 10 am (Meeting Link)
Meetings are traditionally scheduled for the 3rd Friday of the month at 10 am ET. THIS IS A REVISED SCHEDULE

Clinical Trials WG: Friday, Feb. 18 at 10:30 am ET (Meeting Link)
Meetings are traditionally scheduled for every other Friday at 10:30 am ET.

Registry WG (formerly UK Bio Bank): THIS MEETING IS RESCHEDULED- TBD (Meeting Link )
Meetings are traditionally scheduled for every three months on the third Friday at 10 am ET.

GIS-Geographic Information System WG GENERAL Meeting: Monday, Feb. 21 at 10 am ET (Meeting Link)
Meetings are traditionally scheduled for every other Monday at 10 am ET.

OHDSI SHOUTOUTS

Congratulations to Peter Rijnbeek and all of our collaborators at the Erasmus University Medical Center for being awarded a contract to establish the Coordination Center for the Data Analysis and Real World Interrogation Network (DARWIN EU). As noted in this EHDEN press release, “DARWIN EU will be able to leverage the extensive work done within the European Health Data and Evidence Network (EHDEN) project funded by the Innovative Medicines Initiative (IMI), and the Observational Health Data Sciences and Informatics (OHDSI) community.”

OHDSI UPDATES

• Phenotype Phebruary has begun, and we have six interactive forum threads ongoing discussing different phenotypes developments & evaluation. Each daily post will be linked on this page on OHDSI.org: Phenotype Phebruary Daily Updates – OHDSI. You can find each phenotype topic and post from the last week below; please check them out and continue the conversations. Thank you to Azza Shoaibi, Gowtham Rao, Joel Swerdel, Allan Wu and Patrick Ryan for leading these discussions.

Feb 7 • Neutropenia

Feb 8 • Kidney Stones

Feb 9 • Delirium

Feb 10 • Systemic Lupus Erythematosus

Feb 11 • Suicide Attempts

Feb 12 • Parkinson’s Disease and Parkinsonism

Feb 13 • Attention Deficit Hyperactivity Disorder

Feb 14 • Hypertension

• The next CBER Best Seminar will be provided by a veteran collaborator within the OHDSI community. Nicole Pratt (Professor, University of South Australia) will present on “Evaluating Use of Methods for Adverse Event Under Surveillance For Vaccines” at 11 am ET on Wednesday, Feb. 23. This seminar is free and open to the public; you can register here.

The 2022 OHDSI European Symposium, which will be held at the Steam Ship Rotterdam in The Netherlands, will be held June 24-26. The main symposium will be June 24, and tutorials will be held June 25-26. For more information and the registration link, please visit the symposium homepage.

The #OHDSISocialShowcase continues this week, as we highlight all the global research presented at the OHDSI Symposium. Here is a look at the research being shared this week on Twitter and LinkedIn; please check them out and share with your own networks!

Monday: Scaling OHDSI open-source community projects, lessons learned by Oncology Work group

Tuesday: CemConnector: A RESTFul application programing interface and client library for the Common Evidence Model (CEM)

Wednesday: Disease Progression Modeling Workbench 360

Thursday: Evaluating Patient Count Vs Hospitalization Risk for Common Clinical Trial Eligibility Criteria: A Case Study for Relapsed/Refractory Lymphoma/Leukemia

Friday: Representation of investigational drugs in the OMOP CDM

Accessing MSTeams: To join OHDSI Teams, please fill out this form: Join OHDSI Teams
If you are already in the OHDSI Teams environment and you would like to join work groups in teams, please fill out this form: Join Workgroups, Chapters, and Studies

Teams Best Practices and Guidance : For guidance on MS Teams, please log into OHDSI Teams and check out this channel located in the OHDSI Team Teams Best Practices and Guidance
**you can also find the document on our website ohdsi.org under “Collaborate with OHDSI in MS Teams.”

Please continue to collaborate in our MS Teams environment, check out the OHDSI website and forums, and follow us on all platforms, including Twitter and LinkedIn to get continued updates and information on everything happening in our community

t